HK1012412A1 - Hepatitis g virus and molecular cloning thereof - Google Patents

Hepatitis g virus and molecular cloning thereof

Info

Publication number
HK1012412A1
HK1012412A1 HK98113378A HK98113378A HK1012412A1 HK 1012412 A1 HK1012412 A1 HK 1012412A1 HK 98113378 A HK98113378 A HK 98113378A HK 98113378 A HK98113378 A HK 98113378A HK 1012412 A1 HK1012412 A1 HK 1012412A1
Authority
HK
Hong Kong
Prior art keywords
hgv
hepatitis
antigens
methods
virus
Prior art date
Application number
HK98113378A
Other languages
English (en)
Inventor
Jungsuh P Kim
Kirk E Fry
Lavonne Marie Young
Jeffrey M Linnen
John Wages
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of HK1012412A1 publication Critical patent/HK1012412A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
HK98113378A 1994-05-20 1998-12-15 Hepatitis g virus and molecular cloning thereof HK1012412A1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US24698594A 1994-05-20 1994-05-20
US28554394A 1994-08-03 1994-08-03
US28555894A 1994-08-03 1994-08-03
US32972994A 1994-10-26 1994-10-26
US34427194A 1994-11-23 1994-11-23
US35750994A 1994-12-16 1994-12-16
US38988695A 1995-02-15 1995-02-15
PCT/US1995/006169 WO1995032291A2 (fr) 1994-05-20 1995-05-19 Virus de l'hepatite g et son clonage moleculaire

Publications (1)

Publication Number Publication Date
HK1012412A1 true HK1012412A1 (en) 1999-07-30

Family

ID=27569460

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113378A HK1012412A1 (en) 1994-05-20 1998-12-15 Hepatitis g virus and molecular cloning thereof

Country Status (16)

Country Link
EP (1) EP0763114B1 (fr)
JP (2) JPH10503642A (fr)
KR (1) KR100394693B1 (fr)
CN (1) CN1125877C (fr)
AT (1) ATE210185T1 (fr)
CA (1) CA2190860A1 (fr)
DE (1) DE69524407T2 (fr)
DK (1) DK0763114T3 (fr)
ES (1) ES2170152T3 (fr)
FI (1) FI112249B (fr)
HK (1) HK1012412A1 (fr)
MX (1) MX9605666A (fr)
NO (1) NO323849B1 (fr)
NZ (1) NZ288000A (fr)
PT (1) PT763114E (fr)
WO (1) WO1995032291A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5843450A (en) * 1994-02-14 1998-12-01 Abbott Laboratories Hepatitis GB Virus synthetic peptides and uses thereof
US6558898B1 (en) 1994-02-14 2003-05-06 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6720166B2 (en) 1994-02-14 2004-04-13 Abbott Laboratories Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US5981172A (en) * 1994-02-14 1999-11-09 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
US6451578B1 (en) 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
US6586568B1 (en) 1994-02-14 2003-07-01 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5807670A (en) * 1995-08-14 1998-09-15 Abbott Laboratories Detection of hepatitis GB virus genotypes
US5709997A (en) * 1995-08-14 1998-01-20 Abbott Laboratories Nucleic acid detection of hepatitis GB virus
US5955318A (en) * 1995-08-14 1999-09-21 Abbott Laboratories Reagents and methods useful for controlling the translation of hepatitis GBV proteins
ZA969715B (en) * 1995-11-21 1998-05-20 Boehringer Mannheim Gmbh Amplification of nucleic acids and detection of a novel hepatitis Non-A/Non-B/Non-C/Non-D/Non-E virus.
IT1283893B1 (it) * 1996-01-24 1998-05-07 Sorin Biomedica Diagnostics Sp Metodo per rilevare sequenze nucleotidiche di virus associati a epatiti nona-none, peptidi e composizioni
DE19613406A1 (de) * 1996-04-03 1997-10-09 Boehringer Mannheim Gmbh Expression von HGV-Antigenen und deren Verwendung
IT1284630B1 (it) * 1996-04-17 1998-05-21 Sorin Biomedica Diagnostics Sp Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi.
US5766916A (en) * 1996-04-24 1998-06-16 Genelabs Technologies, Inc. Hepatitis G virus protease
EP0832901A1 (fr) * 1996-09-18 1998-04-01 Roche Diagnostics GmbH Anticorps contre le virus hépatite G, leur utilisation diagnostique pour la détection de HGV, et comme agent thérapeutique
ATE482974T1 (de) * 1997-11-06 2010-10-15 Innogenetics Nv Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
GB0009756D0 (en) * 2000-04-19 2000-06-07 Glaxo Group Ltd Test method
WO2014097762A1 (fr) * 2012-12-20 2014-06-26 国立大学法人熊本大学 Anticorps dirigé contre la grippe aviaire hautement pathogène
US9594163B2 (en) 2013-04-15 2017-03-14 Electronics And Telecommunications Research Institute Security and surveillance system and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4046489A (en) * 1988-07-06 1990-02-05 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
WO1994018217A1 (fr) * 1993-02-03 1994-08-18 Abbott Laboratories Reactifs des hepatites non-a, non-b, non-c, non-d, non-e et leurs procedes d'utilisation
CA2166313A1 (fr) * 1994-02-14 1995-08-17 John N. Simons Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation

Also Published As

Publication number Publication date
ATE210185T1 (de) 2001-12-15
KR970703425A (ko) 1997-07-03
DE69524407T2 (de) 2002-08-01
FI964605A (fi) 1997-01-15
CN1125877C (zh) 2003-10-29
WO1995032291A2 (fr) 1995-11-30
JP4296174B2 (ja) 2009-07-15
ES2170152T3 (es) 2002-08-01
JP2006115845A (ja) 2006-05-11
JPH10503642A (ja) 1998-04-07
NZ288000A (en) 1998-09-24
FI112249B (fi) 2003-11-14
NO323849B1 (no) 2007-07-09
NO964721D0 (no) 1996-11-07
FI964605A0 (fi) 1996-11-18
CA2190860A1 (fr) 1995-11-30
WO1995032291A3 (fr) 1996-03-07
EP0763114A2 (fr) 1997-03-19
NO964721L (no) 1997-01-17
DE69524407D1 (de) 2002-01-17
AU2689595A (en) 1995-12-18
KR100394693B1 (ko) 2003-12-31
PT763114E (pt) 2002-05-31
MX9605666A (es) 1998-05-31
EP0763114B1 (fr) 2001-12-05
AU684177B2 (en) 1997-12-04
CN1153529A (zh) 1997-07-02
DK0763114T3 (da) 2002-04-02

Similar Documents

Publication Publication Date Title
HK1012412A1 (en) Hepatitis g virus and molecular cloning thereof
CA2079912A1 (fr) Epitopes du virus de l'hepatite c
DK480889A (da) Non-a, non-b, hepatitisvirus-antigenpeptid, cdna kodende derfor, fremgangsmaade til detektering deraf og bakteriestamme indeholdende et saadant cdna
KR960703136A (ko) 탠덤 합성 hiv-1 펩티드들
CA2047792A1 (fr) Peptides synthetiques specifiques pour la detection des anticorps diriges contre le vhc, diagnostic de l'infection a vhc et sa prevention grace a des vaccins
ZA912305B (en) Novel vaccine
KR940703851A (ko) E형 간염 바이러스 펩타이드 항원 및 항체(hepatitis e virus peptide antigens and antibodies)
CA2057052A1 (fr) Agent viral de l'hepatire non-a, non-b transmis par voie enterique et epitopes caracteristiques
WO1996021734A3 (fr) Antigenes p15 et tyrosinase du melanome et leur utilisation dans des procedes diagnostiques et therapeutiques
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
WO1995032290A3 (fr) Agents de l'hepatite non a/non b/non c/non d/non e et leur clonage moleculaire
CA2075366A1 (fr) Peptides ou polypeptides immunologiquement actifs tires du parvovirus b19
EP0879244A4 (fr) Polypeptides et vaccins de recombinaison de mycoplasmes
AU9629498A (en) Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
GR3015437T3 (en) Non-a non-b sequences.
PT97428A (pt) Processo para a preparacao de epitopos do virus da hepatite c
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
IT1241581B (it) Peptidi sintetici contenenti sequenze di aminoacidi che definiscono epitopi immunoreattivi contro anticorpi umani anti hcv, utili per l'allestimento di dosaggi immunologici.
KR930000127A (ko) 비(非)a 비(非)b형 간염 진단방법 및 백신

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100519